Skip to main content
Top
Gepubliceerd in: Quality of Life Research 1/2014

01-02-2014 | Brief Communication

Association of patient demographics on quality of life in a sample of adult patients with cardiac arrhythmias

Auteurs: Derek H. Tang, Adrienne M. Gilligan, Klaus Romero

Gepubliceerd in: Quality of Life Research | Uitgave 1/2014

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Identify predictors of quality of life (QOL) in patients with any form of cardiac arrhythmia (CA).

Methods

Data from the Medical Panel Expenditure Survey were analyzed from 2004 to 2009. Patients aged ≥18 with any form of CA (identified via ICD-9-CM codes) were included. Primary outcomes included the physical and mental component scores (PCS and MCS) of the Short-Form 12 version 2 (SF-12) and EuroQoL-5D (EQ-5D) utility scores (US version). Patient demographics included insurance status, urban status, geographical region, federal poverty level, education, comorbidities, and disease-related risk factors of CA.

Results

Approximately 5,750,440 individuals had CA. Non-Hispanic Whites had the highest SF-12 MCS (mean 50.9; p < 0.001 across racial groups) and utility scores (mean 0.76; p < 0.001 across racial groups). Patients with both private and public insurance had significantly higher PCS (p = 0.001) and MCS (p < 0.001) in comparison with patients only covered by public insurance. Patients on antiarrhythmic agents had higher SF-12 MCS (51.4 vs. 48.4; p < 0.001) compared to individuals not on antiarrhythmic agents.

Conclusions

Significantly lower QOL existed in specific subpopulations (e.g., patients with only public health insurance, racial/ethnic minorities, and those not exposed to antiarrhythmic agents) within the CA population.
Literatuur
2.
go back to reference The American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2009). Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 119, e21–e181.CrossRef The American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2009). Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 119, e21–e181.CrossRef
3.
go back to reference Coyne, K. S., Paramore, C., Grandy, S., Mercder, M., Reynolds, M., & Zimetbaum, P. (2006). Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value in Health, 9, 348–356.PubMedCrossRef Coyne, K. S., Paramore, C., Grandy, S., Mercder, M., Reynolds, M., & Zimetbaum, P. (2006). Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value in Health, 9, 348–356.PubMedCrossRef
4.
go back to reference Rohrbacker, N. J., Kleinman, N. L., White, S. A., March, J. L., & Reynolds, M. R. (2010). The burden of atrial fibrillation and other cardiac arrhythmias in an employed population: Associated costs, absences, and objective productivity loss. Journal of Occupational and Environmental Medicine, 52, 383–391.PubMedCrossRef Rohrbacker, N. J., Kleinman, N. L., White, S. A., March, J. L., & Reynolds, M. R. (2010). The burden of atrial fibrillation and other cardiac arrhythmias in an employed population: Associated costs, absences, and objective productivity loss. Journal of Occupational and Environmental Medicine, 52, 383–391.PubMedCrossRef
5.
go back to reference Le Heuzey, J. Y., Paziaud, O., Piot, O., Said, M. A., Copie, X., Lavergne, T., et al. (2004). Cost of care distribution in atrial fibrillation patients: The COCAF study. American Heart Journal, 147, 121–126.PubMedCrossRef Le Heuzey, J. Y., Paziaud, O., Piot, O., Said, M. A., Copie, X., Lavergne, T., et al. (2004). Cost of care distribution in atrial fibrillation patients: The COCAF study. American Heart Journal, 147, 121–126.PubMedCrossRef
6.
go back to reference Reynolds, M. R., Essebag, V., Zimetbaum, P., & Cohen, D. J. (2007). Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: The FRACTAL registry. Journal of Cardiovascular Electrophysiology, 18, 628–633.PubMedCentralPubMedCrossRef Reynolds, M. R., Essebag, V., Zimetbaum, P., & Cohen, D. J. (2007). Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: The FRACTAL registry. Journal of Cardiovascular Electrophysiology, 18, 628–633.PubMedCentralPubMedCrossRef
7.
go back to reference Dorian, P., Paquette, M., Newman, D., Green, M., Connolly, S. J., Talajic, M., et al. (2002). Quality of life improves with treatment in the Canadian trial of atrial fibrillation. American Heart Journal, 143, 984–990.PubMedCrossRef Dorian, P., Paquette, M., Newman, D., Green, M., Connolly, S. J., Talajic, M., et al. (2002). Quality of life improves with treatment in the Canadian trial of atrial fibrillation. American Heart Journal, 143, 984–990.PubMedCrossRef
8.
go back to reference Lönnerholm, S., Blomström, P., Nilsson, L., Oxelbark, S., Jideus, L., & Blomström-Lundqvist, C. (2000). Effects of the maze operation on health-related quality of life in patients with atrial fibrillation. Circulation, 101, 2607–2611.PubMedCrossRef Lönnerholm, S., Blomström, P., Nilsson, L., Oxelbark, S., Jideus, L., & Blomström-Lundqvist, C. (2000). Effects of the maze operation on health-related quality of life in patients with atrial fibrillation. Circulation, 101, 2607–2611.PubMedCrossRef
9.
go back to reference Pappone, C., Rosanio, S., Augello, G., Gallus, G., Vicedomini, G., Mazzone, P., et al. (2003). Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study. Journal of the American College of Cardiology, 42, 185–197.PubMedCrossRef Pappone, C., Rosanio, S., Augello, G., Gallus, G., Vicedomini, G., Mazzone, P., et al. (2003). Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study. Journal of the American College of Cardiology, 42, 185–197.PubMedCrossRef
10.
go back to reference Singh, B. N., Singh, S. N., Reda, D. J., Tang, X. C., Lopez, B., Harris, C. L., et al. (2005). Amiodarone versus sotalol for atrial fibrillation. New England Journal of Medicine, 352, 1861–1872.PubMedCrossRef Singh, B. N., Singh, S. N., Reda, D. J., Tang, X. C., Lopez, B., Harris, C. L., et al. (2005). Amiodarone versus sotalol for atrial fibrillation. New England Journal of Medicine, 352, 1861–1872.PubMedCrossRef
12.
go back to reference Chuang, L. H., & Kind, P. (2009). Converting the SF-12 into the EQ-5D: an empirical comparison of methodologies. Pharmacoeconomics, 27, 491–505.PubMedCrossRef Chuang, L. H., & Kind, P. (2009). Converting the SF-12 into the EQ-5D: an empirical comparison of methodologies. Pharmacoeconomics, 27, 491–505.PubMedCrossRef
13.
go back to reference Chisholm, M. A., Wells, B. G., Schwinghammer, T. L., Malone, P. M., Kolesar, J. M., & Rotschafer, J. C. (Eds.). (2007). Pharmacotherapy principles and practice. New York: McGraw Hill Medical. Chisholm, M. A., Wells, B. G., Schwinghammer, T. L., Malone, P. M., Kolesar, J. M., & Rotschafer, J. C. (Eds.). (2007). Pharmacotherapy principles and practice. New York: McGraw Hill Medical.
14.
go back to reference D’Hoore, W., Bouckaert, A., & Tilquin, C. (1996). Practical considerations on the use of the Charlson Comorbidity Index with administrative databases. Journal of Clinical Epidemiology, 49, 1429–1433.PubMedCrossRef D’Hoore, W., Bouckaert, A., & Tilquin, C. (1996). Practical considerations on the use of the Charlson Comorbidity Index with administrative databases. Journal of Clinical Epidemiology, 49, 1429–1433.PubMedCrossRef
16.
go back to reference Lim, L. Y., & Fisher, J. D. (1999). Use of the 12-item Short-Form (SF-12) Health Survey in Australian heart and stroke population. Quality of Life Research, 8, 1–8.PubMedCrossRef Lim, L. Y., & Fisher, J. D. (1999). Use of the 12-item Short-Form (SF-12) Health Survey in Australian heart and stroke population. Quality of Life Research, 8, 1–8.PubMedCrossRef
17.
go back to reference Dorian, P., & Mangat, I. (2003). Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian trial of atrial fibrillation. Cardiac Electrophysiology Review, 7, 276–279.PubMedCrossRef Dorian, P., & Mangat, I. (2003). Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian trial of atrial fibrillation. Cardiac Electrophysiology Review, 7, 276–279.PubMedCrossRef
18.
go back to reference Ware, J. E., Snow, K. K., Kosinski, M. A., & Gandek, B. (1993). SF-36 health survey manual and interpretation guide. Boston: The Health Institute, New England Medical Center. Ware, J. E., Snow, K. K., Kosinski, M. A., & Gandek, B. (1993). SF-36 health survey manual and interpretation guide. Boston: The Health Institute, New England Medical Center.
19.
go back to reference Ware, J. E., Bayliss, M. S., Rogers, W. H., Kosinski, M. A., & Tarlov, A. R. (1996). Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and Fee-for-Service Systems: Results from the Medical Outcomes Study. Journal of the American Medical Association, 276, 1039–1047.PubMedCrossRef Ware, J. E., Bayliss, M. S., Rogers, W. H., Kosinski, M. A., & Tarlov, A. R. (1996). Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and Fee-for-Service Systems: Results from the Medical Outcomes Study. Journal of the American Medical Association, 276, 1039–1047.PubMedCrossRef
20.
go back to reference Burdine, J. N., Felix, M., Abel, A. L., Wiltraut, C. J., & Musselman, Y. J. (2000). The SF-12 as a population health measure: An exploratory examination of potential for application. Health Services Research, 35, 885–903.PubMed Burdine, J. N., Felix, M., Abel, A. L., Wiltraut, C. J., & Musselman, Y. J. (2000). The SF-12 as a population health measure: An exploratory examination of potential for application. Health Services Research, 35, 885–903.PubMed
21.
go back to reference Cheadle, A., Wagner, E., Koepsell, T., Kristal, A., & Patrick, D. (1992). Environmental indicators: A tool for evaluating community-based health promotion programs. American Journal of Preventive Medicine, 8, 345–350.PubMed Cheadle, A., Wagner, E., Koepsell, T., Kristal, A., & Patrick, D. (1992). Environmental indicators: A tool for evaluating community-based health promotion programs. American Journal of Preventive Medicine, 8, 345–350.PubMed
22.
go back to reference Marmot, M. G., Bobak, M., Smith. G. D. (1995). Explanations for social inequalities in health. Society and Health. 46–92. Marmot, M. G., Bobak, M., Smith. G. D. (1995). Explanations for social inequalities in health. Society and Health. 46–92.
Metagegevens
Titel
Association of patient demographics on quality of life in a sample of adult patients with cardiac arrhythmias
Auteurs
Derek H. Tang
Adrienne M. Gilligan
Klaus Romero
Publicatiedatum
01-02-2014
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 1/2014
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-013-0445-2

Andere artikelen Uitgave 1/2014

Quality of Life Research 1/2014 Naar de uitgave